| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 43.76B | 44.82B | 46.99B | 42.11B | 35.81B | 34.71B |
| Gross Profit | 9.39B | 9.23B | 8.66B | 7.06B | 5.81B | 6.40B |
| EBITDA | 3.22B | 3.07B | 4.41B | 552.45M | 224.09M | -19.93M |
| Net Income | 502.19M | 166.22M | 885.67M | -1.53B | -1.11B | -1.29B |
Balance Sheet | ||||||
| Total Assets | 35.79B | 39.14B | 37.75B | 40.30B | 36.02B | 32.90B |
| Cash, Cash Equivalents and Short-Term Investments | 6.16B | 6.45B | 5.14B | 5.97B | 3.75B | 4.66B |
| Total Debt | 17.42B | 17.79B | 16.00B | 20.70B | 17.97B | 13.93B |
| Total Liabilities | 22.82B | 25.76B | 25.83B | 29.13B | 24.82B | 21.31B |
| Stockholders Equity | 12.97B | 13.38B | 11.91B | 11.17B | 11.21B | 11.59B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 105.48M | 1.69B | -97.12M | -4.26B | -772.32M |
| Operating Cash Flow | 0.00 | 855.89M | 2.42B | 558.64M | -3.57B | -152.22M |
| Investing Cash Flow | 0.00 | -408.51M | 2.57B | -569.39M | -131.19M | -702.29M |
| Financing Cash Flow | 0.00 | 573.12M | -6.00B | 2.00B | 2.50B | -168.32M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥44.60B | 71.35 | ― | 4.43% | 0.63% | -24.87% | |
79 Outperform | ¥39.57B | 310.64 | ― | 2.26% | 20.13% | 33.43% | |
70 Outperform | ¥44.85B | 14.45 | ― | 2.93% | -0.90% | -13.24% | |
70 Outperform | ¥257.81B | 6.34 | 12.24% | 2.31% | -2.36% | -61.50% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | ¥10.14B | 3.50 | ― | 1.64% | -11.47% | ― | |
47 Neutral | ¥5.04B | 44.10 | ― | 2.01% | 13.56% | ― |